A Phase I Clinical Trial to Evaluate CU-10101 Unguent | MicrobiomeTrials← Back to trialsNCT06744569
A Phase I Clinical Trial to Evaluate CU-10101 Unguent
ENROLLING_BY_INVITATIONPHASE1INTERVENTIONAL
Trial Details
Start: 2024-09-12Est. Completion: 2026-09-09
Enrollment target: 64 participants Locations- Shanghai Skin Disease Hospital, Shanghai, Shanghai Municipality, China
Other microbiome trials you might be interested in
PsoriasisEczemaJAK Inhibitor
Emerging evidence indicates that psoriasis and eczema can coexist in the same patient, with reported co-prevalence rates…
Shanghai, ChinaCompleted Aug 30, 2026
Skin Barrier to Water LossPASI /SCORAD Index
This randomized, double-blind, placebo-controlled clinical trial is designed to evaluate the safety and efficacy of topi…
Shenzhen, ChinaCompleted Mar 5, 2026